{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:42:27Z","timestamp":1791996147194,"version":"4.4.0"},"reference-count":279,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,12]],"date-time":"2014-11-12T00:00:00Z","timestamp":1415750400000},"content-version":"vor","delay-in-days":42,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["BI1292\/4-1"],"award-info":[{"award-number":["BI1292\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["BI1292\/5-1"],"award-info":[{"award-number":["BI1292\/5-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"German Hypertension League"},{"name":"Deusches Zentrum f\u00fcr Herz-Kreislaufforschung"},{"name":"Deusches Zentrum f\u00fcr Herz-Kreislaufforschung","award":["KFO218\/2"],"award-info":[{"award-number":["KFO218\/2"]}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000641","name":"ICEMED (Helmholtz-Alliance)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000641","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.pharmthera.2014.04.007","type":"journal-article","created":{"date-parts":[[2014,4,27]],"date-time":"2014-04-27T08:46:23Z","timestamp":1398588383000},"page":"12-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"title":["Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome"],"prefix":"10.1016","volume":"144","author":[{"given":"Nina","family":"Schlueter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"de Sterke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Willmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Spranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas L.","family":"Birkenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2014.04.007_bb0005","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/sj.jhh.1002210","article-title":"Plasma N terminal pro-brain natriuretic peptide levels and its determinants in a multi-ethnic population","volume":"21","author":"Abdulle","year":"2007","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0010","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s11695-013-0889-z","article-title":"Gastric bypass surgery elevates NT-ProBNP levels","volume":"23","author":"Abrahamsson","year":"2013","journal-title":"Obes Surg"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.biocel.2009.12.009","article-title":"Lipolysis in adipocytes","volume":"42","author":"Ahmadian","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0020","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1210\/rp.59.1.169","article-title":"Hypertension and obesity","volume":"59","author":"Aneja","year":"2004","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0025","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/07853899709002451","article-title":"Differences in lipolysis between human subcutaneous and omental adipose tissues","volume":"27","author":"Arner","year":"1995","journal-title":"Ann Med"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0030","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI67383","article-title":"Atrial natriuretic peptide is negatively regulated by microRNA-425","volume":"123","author":"Arora","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0035","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/ajh\/hpt145","article-title":"Metabolic rather than body composition measurements are associated with lower serum natriuretic peptide concentrations in normal weight and obese men","volume":"27","author":"Asferg","year":"2013","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1000","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/HYPERTENSIONAHA.111.00791","article-title":"Relative atrial natriuretic peptide deficiency and inadequate renin and angiotensin ii suppression in obese hypertensive men","volume":"62","author":"Asferg","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/ajcn\/42.1.83","article-title":"Enhanced thermogenic responsiveness during chronic ephedrine treatment in man","volume":"42","author":"Astrup","year":"1985","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0050","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2337\/db06-0883","article-title":"Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice","volume":"56","author":"Ayala","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0055","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/1479164113490179","article-title":"Adiponectin in coronary heart disease and newly diagnosed impaired glucose tolerance","volume":"10","author":"Azizi Ghanbari","year":"2013","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0060","article-title":"Changes to the cardiac biomarkers of non-elite athletes completing the 2009 London Marathon","author":"Baker","year":"2013","journal-title":"Emerg Med J"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb2025","doi-asserted-by":"crossref","first-page":"e12793","DOI":"10.1371\/journal.pone.0012793","article-title":"New Function for an Old Enzyme: NEP Deficient Mice Develop Late-Onset Obesity","volume":"5","author":"Becker","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cccn.2003.10.026","article-title":"The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma","volume":"340","author":"Belenky","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0070","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1210\/en.2007-0572","article-title":"Impairment of the natriuretic peptide system in follitropin receptor knockout mice and reversal by estradiol: implications for obesity-associated hypertension in menopause","volume":"149","author":"Belo","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0075","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00004872-199207000-00002","article-title":"Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension","volume":"10","author":"Bevan","year":"1992","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0080","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1161\/HYPERTENSIONAHA.110.165159","article-title":"Metabolic actions could confound advantageous effects of combined angiotensin II receptor and neprilysin inhibition","volume":"57","author":"Birkenfeld","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0085","doi-asserted-by":"crossref","first-page":"e43238","DOI":"10.1371\/journal.pone.0043238","article-title":"Atrial natriuretic peptide and adiponectin interactions in man","volume":"7","author":"Birkenfeld","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0090","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1210\/jc.2004-1953","article-title":"Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans","volume":"90","author":"Birkenfeld","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0095","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1210\/jc.2006-1084","article-title":"\u03b2-Adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation","volume":"91","author":"Birkenfeld","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0100","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.2337\/db08-0649","article-title":"Atrial natriuretic peptide induces postprandial lipid oxidation in humans","volume":"57","author":"Birkenfeld","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cmet.2011.06.009","article-title":"Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice","volume":"14","author":"Birkenfeld","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0110","doi-asserted-by":"crossref","first-page":"36163","DOI":"10.1074\/jbc.M111.228817","article-title":"Influence of the hepatic eukaryotic initiation factor 2alpha (eIF2alpha) endoplasmic reticulum (ER) stress response pathway on insulin-mediated ER stress and hepatic and peripheral glucose metabolism","volume":"286","author":"Birkenfeld","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0115","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.26672","article-title":"Non alcoholic fatty liver disease, hepatic insulin resistance and type 2 diabetes","volume":"59","author":"Birkenfeld","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0120","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00210-012-0791-6","article-title":"Antihypertrophic effects of combined inhibition of the renin\u2013angiotensin system (RAS) and neutral endopeptidase (NEP) in progressive, tachycardia-induced experimental heart failure","volume":"385","author":"Birner","year":"2012","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0125","first-page":"803","article-title":"Atrial natriuretic factor increases in response to an acute glucose load","volume":"12","author":"B\u00f6hlen","year":"1994","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0130","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1172\/JCI59701","article-title":"Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes","volume":"122","author":"Bordicchia","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0135","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0735-1097(01)01172-X","article-title":"Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects","volume":"37","author":"Brunner-La Rocca","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0140","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/080370500439092","article-title":"Normal responses of atrial natriuretic factor and renal tubular function to sodium loading in hypertension-prone humans","volume":"9","author":"Bruun","year":"2000","journal-title":"Blood Press"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0145","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1517\/14656566.2013.799665","article-title":"An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors","volume":"14","author":"Bruzziches","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0150","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1021\/bi051253d","article-title":"A sensitive method for determining the phosphorylation status of natriuretic peptide receptors: cGK-Ialpha does not regulate NPR-A","volume":"45","author":"Bryan","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0155","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1042\/cs0970689","article-title":"Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice","volume":"97","author":"Buckley","year":"1999","journal-title":"Clin Sci"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0160","doi-asserted-by":"crossref","first-page":"F863","DOI":"10.1152\/ajprenal.1984.247.5.F863","article-title":"Effects of synthetic atrial natriuretic factor on renal function and renin release","volume":"247","author":"Burnett","year":"1984","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0800","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.metabol.2004.07.020","article-title":"Differential regulation of atrial natriuretic peptides and adrenergic receptor dependent lipolytic pathways in human adipose tissue","volume":"54","author":"Moro","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0165","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2011.05.011","article-title":"A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community","volume":"58","author":"Cannone","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0170","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.2337\/dc12-2337","article-title":"The atrial natriuretic peptide genetic variant rs5068 is associated with a favorable cardiometabolic phenotype in a Mediterranean population","volume":"36","author":"Cannone","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0175","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1128\/MCB.24.7.3057-3067.2004","article-title":"p38 mitogen-activated protein kinase is the central regulator of cyclic AMP-dependent transcription of the brown fat uncoupling protein 1 gene","volume":"24","author":"Cao","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0180","doi-asserted-by":"crossref","first-page":"27077","DOI":"10.1074\/jbc.M101049200","article-title":"beta-Adrenergic activation of p38 MAP kinase in adipocytes: cAMP induction of the uncoupling protein 1 (UCP1) gene requires p38 MAP kinase","volume":"276","author":"Cao","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pharmthera.2013.05.009","article-title":"Brown adipose tissue in humans: therapeutic potential to combat obesity","volume":"140","author":"Carey","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0190","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.amjcard.2010.01.016","article-title":"Relation of B-type natriuretic peptide levels to body mass index after comprehensive lifestyle changes","volume":"105","author":"Chainani-Wu","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0195","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1007\/s00464-010-1565-1","article-title":"B-type natriuretic peptide increases after gastric bypass surgery and correlates with weight loss","volume":"25","author":"Changchien","year":"2011","journal-title":"Surg Endosc"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0205","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/jama.2013.282190","article-title":"Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial","volume":"310","author":"Chen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0215","first-page":"1362","article-title":"The significance of natriuretic peptide in treatment of pulmonary hypertension after mitral valve replacement","volume":"47","author":"Chen","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0210","doi-asserted-by":"crossref","first-page":"I-134","DOI":"10.1161\/CIRCULATIONAHA.106.697250","article-title":"Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study","volume":"116","author":"Chen","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0220","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.amjcard.2011.05.033","article-title":"Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals","volume":"108","author":"Cheng","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0200","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.amjcard.2010.06.076","article-title":"Effect of weight loss after weight loss surgery on plasma N-terminal pro-B-type natriuretic peptide levels","volume":"106","author":"Chen-Tournoux","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0225","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/CIRCHEARTFAILURE.112.968701","article-title":"N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: multi-ethnic study of atherosclerosis","volume":"5","author":"Choi","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0230","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1172\/JCI24867","article-title":"Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice","volume":"116","author":"Choi","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb9000","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/hmg\/ddp169","article-title":"The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects","volume":"18","author":"Choquet","year":"2009","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0235","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1073\/pnas.071389098","article-title":"Dwarfism and early death in mice lacking C-type natriuretic peptide","volume":"98","author":"Chusho","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0240","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0026-0495(93)90040-U","article-title":"Effect of glucose, insulin, and hypertonicity on atrial natriuretic peptide levels in man","volume":"42","author":"Clark","year":"1993","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0245","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(05)77712-6","article-title":"Lack of efficacy of neutral endopeptidase inhibitor ecadotril in heart failure","volume":"351","author":"Cleland","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0250","doi-asserted-by":"crossref","first-page":"H17","DOI":"10.1152\/ajpheart.00684.2005","article-title":"Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications","volume":"290","author":"Clerico","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0255","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1515\/CCLM.2002.060","article-title":"The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex","volume":"40","author":"Clerico","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0260","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1210\/jcem-70-3-582","article-title":"The physiological role of atrial natriuretic hormone in the regulation of aldosterone and salt and water metabolism","volume":"70","author":"Clinkingbeard","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0265","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1042\/cs0770663","article-title":"Effects of insulin on human adipose tissue metabolism in vivo","volume":"77","author":"Coppack","year":"1989","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0270","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.2337\/db12-0763","article-title":"Cardiac natriuretic peptides: contributors to cardiac cachexia or possible anti-obesity agents or both?","volume":"61","author":"Costello-Boerrigter","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0275","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0195-668X(03)00476-7","article-title":"Clinical applications of B-type natriuretic peptide (BNP) testing","volume":"24","author":"Cowie","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0280","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","article-title":"Identification and importance of brown adipose tissue in adult humans","volume":"360","author":"Cypess","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0285","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/CIRCULATIONAHA.105.555573","article-title":"Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study","volume":"112","author":"Das","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0290","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2337\/db06-1180","article-title":"Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor: effect on vascular and neural disease","volume":"56","author":"Davidson","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0300","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0024-3205(81)90370-2","article-title":"A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats","volume":"28","author":"deBold","year":"1981","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0305","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/00004872-199715120-00074","article-title":"Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients","volume":"15","author":"Dessi-Fulgheri","year":"1997","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0310","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.yjmcc.2011.03.013","article-title":"Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation","volume":"51","author":"Dickey","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0315","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0320","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pupt.2012.11.001","volume":"26","author":"Edelson","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0325","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1073\/pnas.89.18.8537","article-title":"Mechanism of hormone-stimulated lipolysis in adipocytes: translocation of hormone-sensitive lipase to the lipid storage droplet","volume":"89","author":"Egan","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0330","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1172\/JCI64526","article-title":"Natriuretic peptides enhance the oxidative capacity of human skeletal muscle","volume":"122","author":"Engeli","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0335","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1373\/clinchem.2012.194167","article-title":"Prospective evaluation of B-type natriuretic peptide concentrations and the risk of type 2 diabetes in women","volume":"59","author":"Everett","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0340","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0006-2952(03)00154-0","article-title":"Inhibition of leptin release by atrial natriuretic peptide (ANP) in human adipocytes","volume":"65","author":"Fain","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0345","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1463-1326.2000.00071.x","article-title":"Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study","volume":"2","author":"Finer","year":"2000","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0350","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/HYPERTENSIONAHA.110.152892","article-title":"Management of high blood pressure in blacks: an update of the international society on hypertension in blacks consensus statement","volume":"56","author":"Flack","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0355","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1161\/01.CIR.81.6.1860","article-title":"Sympathoinhibitory effects of atrial natriuretic factor in normal humans","volume":"81","author":"Floras","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0360","first-page":"R406","article-title":"Inhibitory effect of atrial natriuretic factor on sympathetic ganglionic neurotransmission in humans","volume":"269","author":"Floras","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0370","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.jacc.2007.02.037","article-title":"Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure","volume":"49","author":"Fonarow","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0375","first-page":"81","article-title":"Cardiac markers (BNP, NT-pro-BNP, troponin I, troponin T, in female amateur runners before and up until three days after a marathon","volume":"54","author":"Frassl","year":"2008","journal-title":"Clin Lab"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0380","first-page":"1119","article-title":"Effect of atriopeptin II on determinants of glomerular filtration rate in the in vitro perfused dog glomerulus","volume":"250","author":"Fried","year":"1986","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0385","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0006-291X(90)91260-Y","article-title":"Novel natriuretic peptide, CNP, potently stimulates cyclic GMP production in rat cultured vascular smooth muscle cells","volume":"170","author":"Furuya","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0390","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0006-291X(91)90627-J","article-title":"C-Type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells","volume":"177","author":"Furuya","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0395","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0400","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0022-2275(20)31162-7","article-title":"The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men","volume":"42","author":"Galitzky","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0405","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/CIRCULATIONAHA.111.063412","article-title":"Chronic inhibition of cGMP phosphodiesterase 5A improves diabetic cardiomyopathy: a randomized, controlled clinical trial using magnetic resonance imaging with myocardial tagging","volume":"125","author":"Giannetta","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0410","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0531-5565(99)00003-0","article-title":"Molecular mechanisms of the effects of sildenafil (VIAGRA\u00ae)","volume":"34","author":"Glossmann","year":"1999","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0415","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/0735-1097(94)00561-4","article-title":"Renal response to candoxatrilat in patients with heart failure","volume":"25","author":"Good","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0420","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2337\/diabetes.52.9.2191","article-title":"Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity","volume":"52","author":"Goodpaster","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0425","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2362.2004.01348.x","article-title":"Natriuretic peptides as markers of preclinical cardiac disease in obesity","volume":"34","author":"Grandi","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0430","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCHEARTFAILURE.110.944694","article-title":"PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study","volume":"4","author":"Guazzi","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0435","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/11631520-000000000-00000","article-title":"Epidemiology and management of hypertension in the hispanic population","volume":"12","author":"Guzman","year":"2012","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0440","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijcard.2008.12.152","article-title":"Short-term changes in circulating insulin and free fatty acids affect Nt-pro-BNP levels in heart failure patients","volume":"144","author":"Halbirk","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0445","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJM200012213432502","article-title":"Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids","volume":"343","author":"Haller","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0450","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1161\/ATVBAHA.111.236554","article-title":"Reduced vascular nitric oxide-cGMP signaling contributes to adipose tissue inflammation during high-fat feeding","volume":"31","author":"Handa","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0455","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.2169\/internalmedicine.50.5926","article-title":"Determinants of serum high molecular weight (HMW) adiponectin levels in patients with coronary artery disease: associations with cardio-renal-anemia syndrome","volume":"50","author":"Hara","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0460","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/326697a0","article-title":"Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption","volume":"326","author":"Harris","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0465","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1432-1033.1978.tb12045.x","article-title":"Brown-adipose-tissue mitochondria: photoaffinity labelling of the regulatory site of energy dissipation","volume":"82","author":"Heaton","year":"1978","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0470","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1007\/s00125-011-2392-1","article-title":"B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose: a randomised placebo-controlled cross-over study in healthy men","volume":"55","author":"Heinisch","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0475","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1373\/clinchem.2004.035923","article-title":"N-terminal pro-B-type natriuretic peptide as an indicator of possible cardiovascular disease in severely obese individuals: comparison with patients in different stages of heart failure","volume":"51","author":"Hermann-Arnhof","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0480","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0196-9781(92)90065-B","article-title":"C-type natriuretic peptide immunoreactivity in human breast vascular endothelial cells","volume":"13","author":"Heublein","year":"1992","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0485","doi-asserted-by":"crossref","first-page":"E775","DOI":"10.1152\/ajpendo.00175.2003","article-title":"Effect of \u03b21- and \u03b22-adrenergic stimulation on energy expenditure, substrate oxidation, and UCP3 expression in humans","volume":"285","author":"Hoeks","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0490","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1172\/JCI17061","article-title":"Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A","volume":"111","author":"Holtwick","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0495","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0735-1097(01)01448-6","article-title":"The relationship between obesity and mortality in patients with heart failure","volume":"38","author":"Horwich","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0500","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/japplphysiol.00707.2003","article-title":"Effect of the volume and intensity of exercise training on insulin sensitivity","volume":"96","author":"Houmard","year":"2004","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0505","doi-asserted-by":"crossref","first-page":"12017","DOI":"10.1073\/pnas.0705070104","article-title":"AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1\u03b1","volume":"104","author":"J\u00e4ger","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0510","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.amjcard.2004.12.032","article-title":"The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) study","volume":"95","author":"Januzzi","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb2000","doi-asserted-by":"crossref","first-page":"10278","DOI":"10.1073\/pnas.96.18.10278","article-title":"Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3)","volume":"96","author":"Jaubert","year":"1999","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0515","first-page":"F63","article-title":"Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans","volume":"274","author":"Jensen","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0520","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.38.12.1595","article-title":"Insulin regulation of lipolysis in nondiabetic and IDDM subjects","volume":"38","author":"Jensen","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0525","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0006-291X(88)80123-2","article-title":"A novel biological effect of atrial natriuretic hormone: inhibition of mesangial cell mitogenesis","volume":"152","author":"Johnson","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0530","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.2337\/db11-1466","article-title":"Comment on: Vila et al. B-type natriuretic peptide modulates ghrelin, hunger, and satiety in healthy men","volume":"61","author":"Jordan","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0535","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/HJH.0b013e3283542da0","article-title":"Obesity, hypertension, and cardiovascular health: is there anything poor Cassandra tries to tell us?","volume":"30","author":"Jordan","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0540","doi-asserted-by":"crossref","first-page":"E1339","DOI":"10.1152\/ajpendo.00272.2009","article-title":"Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice","volume":"297","author":"Kake","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0550","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0006-291X(84)90222-5","article-title":"Identification in rat atrial tissue of multiple forms of natriuretic polypeptides of about 3,000 daltons","volume":"121","author":"Kangawa","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2014.04.007_bb0545","article-title":"Human atrial natriuretic polypeptides (hANP): purification, structure synthesis and biological activity","author":"Kangawa","year":"1984","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0555","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0006-291X(84)90863-5","article-title":"Purification and complete amino acid sequence of beta-rat atrial natriuretic polypeptide (\u03b2-rANP) of 5,000 daltons","volume":"119","author":"Kangawa","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb2005","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1101\/gad.1177604","article-title":"Transcriptional regulatory circuits controlling mitochondrial biogenesis and function","volume":"18","author":"Kelly","year":"2004","journal-title":"Genes & Development"},{"issue":"291","key":"10.1016\/j.pharmthera.2014.04.007_bb0560","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1042\/bj2910083","article-title":"Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11","volume":"1","author":"Kenny","year":"1993","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0565","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1210\/jc.2011-1182","article-title":"Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies","volume":"96","author":"Khan","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0570","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nm.3128","article-title":"GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure","volume":"19","author":"Kim","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0575","first-page":"99","article-title":"Electron microscopy of the atrium of the heart. I. Guinea pig","volume":"14","author":"Kisch","year":"1956","journal-title":"Exp Med Surg"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0580","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1073\/pnas.051625598","article-title":"A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy","volume":"98","author":"Kishimoto","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0585","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/CIRCULATIONAHA.104.530972","article-title":"Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure","volume":"112","author":"Kistorp","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0590","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1005440221914","article-title":"Uncoupling protein \u2014 a useful energy dissipator","volume":"31","author":"Klingenberg","year":"1999","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0595","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.echo.2009.04.009","article-title":"Myocardial function in older male amateur marathon runners: assessment by tissue Doppler echocardiography, speckle tracking, and cardiac biomarkers","volume":"22","author":"Knebel","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0600","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.1672777","article-title":"Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP)","volume":"252","author":"Koller","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0605","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1210\/endo-129-2-1104","article-title":"C-type natriuretic peptide (CNP) in rats and humans","volume":"129","author":"Komatsu","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0610","doi-asserted-by":"crossref","first-page":"E258","DOI":"10.1152\/ajpendo.00767.2009","article-title":"Lipid mobilization in subcutaneous adipose tissue during exercise in lean and obese humans. Roles of insulin and natriuretic peptides","volume":"299","author":"Koppo","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0615","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.2337\/dc11-1959","article-title":"Prospective associations of B-type natriuretic peptide with markers of left ventricular function in individuals with and without type 2 diabetes: an 8-year follow-up of the Hoorn Study","volume":"35","author":"Kroon","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0620","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.2337\/db12-1311","article-title":"Targeting pyruvate carboxylase reduces gluconeogenesis and adiposity and improves insulin resistance","volume":"62","author":"Kumashiro","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0625","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.mcna.2011.06.004","article-title":"Hypertension in obesity","volume":"95","author":"Kurukulasuriya","year":"2011","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0630","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.plipres.2009.05.001","article-title":"Lipolysis and lipid mobilization in human adipose tissue","volume":"48","author":"Lafontan","year":"2009","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0635","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jacc.2011.03.042","article-title":"Influence of sex and hormone status on circulating natriuretic peptides","volume":"58","author":"Lam","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0640","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0002-9149(03)00031-6","article-title":"Body composition and prognosis in chronic systolic heart failure: the obesity paradox","volume":"91","author":"Lavie","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0645","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/0091270009336233","article-title":"Pharmacodynamics pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects","volume":"49","author":"Lee","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0650","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.cmet.2010.11.004","article-title":"Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance","volume":"12","author":"Lee","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0655","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/01.HYP.23.1_Suppl.I20","article-title":"Salt-regulating hormones in young normotensive obese subjects. Effects of saline load","volume":"23","author":"Licata","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0660","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0014-5793(80)80613-2","article-title":"Isolation of the uncoupling protein from brown adipose tissue mitochondria","volume":"113","author":"Lin","year":"1980","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0665","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/oby.20265","article-title":"Dietary patterns, abdominal visceral adipose tissue, and cardiometabolic risk factors in African Americans: the Jackson heart study","volume":"21","author":"Liu","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0670","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1126\/science.2823385","article-title":"Physiological role of silent receptors of atrial natriuretic factor","volume":"238","author":"Maack","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0675","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1042\/cs1010447","article-title":"Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women","volume":"101","author":"Maffei","year":"2001","journal-title":"Clin Sci"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0680","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1210\/jc.2011-2425","article-title":"Low plasma level of atrial natriuretic peptide predicts development of diabetes: the Prospective Malm\u00f6 Diet and Cancer Study","volume":"97","author":"Magnusson","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0685","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/cvr\/cvs281","article-title":"17beta-Estradiol-induced interaction of ER\u03b1 with NPPA regulates gene expression in cardiomyocytes","volume":"96","author":"Mahmoodzadeh","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0690","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMoa020233","article-title":"Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure","volume":"347","author":"Maisel","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0695","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2265.2004.02168.x","article-title":"High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO\/ISH guidelines","volume":"61","author":"Mancini","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0700","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/324473a0","article-title":"Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney","volume":"324","author":"Marin-Grez","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0705","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cjca.2012.11.010","article-title":"Impact of bariatric surgery on N-terminal fragment of the prohormone brain natriuretic peptide and left ventricular diastolic function","volume":"29","author":"Martin","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0710","first-page":"5","article-title":"Recent insights on the molecular mechanisms and therapeutic approaches for cardiac cachexia","volume":"47","author":"Martins","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb2010","doi-asserted-by":"crossref","first-page":"7403","DOI":"10.1073\/pnas.96.13.7403","article-title":"The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system","volume":"96","author":"Matsukawa","year":"1999","journal-title":"PNAS"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0715","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1001\/archinte.164.20.2247","article-title":"Relationship between obesity and b-type natriuretic peptide levels","volume":"164","author":"McCord","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0720","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehm033","article-title":"Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide","volume":"28","author":"McEntegart","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0725","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1464-5491.2000.00318.x","article-title":"Acute hyperglycaemia causes elevation in plasma atrial natriuretic peptide concentrations in type 1 diabetes mellitus","volume":"17","author":"McKenna","year":"2000","journal-title":"Diabet Med"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0730","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11897-010-0016-6","article-title":"CD-NP: an innovative designer natriuretic peptide activator of particulate guanylyl cyclase receptors for cardiorenal disease","volume":"7","author":"McKie","year":"2010","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0735","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jacc.2013.06.046","article-title":"Relationships between right ventricular function, body composition, and prognosis in advanced heart failure","volume":"62","author":"Melenovsky","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb2015","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/hmg\/ddm084","article-title":"Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations","volume":"16","author":"Meirhaeghe","year":"2007","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0740","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jacc.2006.10.048","article-title":"Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA Trial","volume":"49","author":"Mentzer","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0745","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1021\/bc200592c","article-title":"Atrial natriuretic peptide-Fc, ANP-Fc, fusion proteins: semisynthesis, in vitro activity and pharmacokinetics in rats","volume":"23","author":"Mezo","year":"2012","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0750","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cardfail.2005.01.009","article-title":"Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension","volume":"11","author":"Michaels","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0755","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1161\/01.CIR.0000138893.44745.F4","article-title":"Plasma brain natriuretic peptide and N-terminal proatrial natriuretic peptide levels in obese patients: a cause or result of hypertension?","volume":"110","author":"Minami","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0760","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1096\/fj.12-221580","article-title":"Increased cGMP promotes healthy expansion and browning of white adipose tissue","volume":"27","author":"Mitschke","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0765","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbrc.2008.01.017","article-title":"cGMP rescues mitochondrial dysfunction induced by glucose and insulin in myocytes","volume":"367","author":"Mitsuishi","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0770","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.2337\/db09-0393","article-title":"Natriuretic peptides\/cGMP\/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity","volume":"58","author":"Miyashita","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0775","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1507\/endocrj.EJ12-0239","article-title":"Cardiac production of B-type natriuretic peptide is inversely related to the plasma level of free fatty acids in obese individuals \u2014 possible involvement of the insulin resistance","volume":"60","author":"Mizuno","year":"2013","journal-title":"Endocr J"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0780","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1096\/fj.03-1086fje","article-title":"Atrial natriuretic peptide contributes to the physiological control of lipid mobilization in humans","volume":"18","author":"Moro","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0785","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1124\/jpet.103.060913","article-title":"Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells","volume":"308","author":"Moro","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0790","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s00125-007-0614-3","article-title":"Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue","volume":"50","author":"Moro","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0795","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1249\/01.mss.0000170124.51659.52","article-title":"Training enhances ANP lipid-mobilizing action in adipose tissue of overweight men","volume":"37","author":"Moro","year":"2005","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0805","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/00004872-199715110-00007","article-title":"Tissue distribution and localization of natriuretic peptide receptor subtypes in stroke prone spontaneously hypertensive rats","volume":"15","author":"Nagase","year":"1997","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0810","first-page":"907","article-title":"Molecular biology and biochemistry of the natriuretic peptide system. I: natriuretic peptides","volume":"10","author":"Nakao","year":"1992","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0815","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbrc.2010.01.008","article-title":"Reciprocal regulation of natriuretic peptide receptors by insulin in adipose cells","volume":"392","author":"Nakatsuji","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0820","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/bj3270625","article-title":"Furin: a mammalian subtilisin\/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins","volume":"327","author":"Nakayama","year":"1997","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0825","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-2002-32141","article-title":"Defective regulation and action of atrial natriuretic peptide in type 2 diabetes","volume":"34","author":"Nannipieri","year":"2002","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0830","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jacc.2013.03.038","article-title":"Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile","volume":"62","author":"Neeland","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0835","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1021\/bc700294w","article-title":"Reversible pegylation prolongs the hypotensive effect of atrial natriuretic peptide","volume":"19","author":"Nesher","year":"2007","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0840","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.2337\/db13-0749","article-title":"The mammalian INDY homolog is induced by CREB in a rat model of type 2 diabetes","volume":"63","author":"Neuschafer-Rube","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0845","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/ng.328","article-title":"Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure","volume":"41","author":"Newton-Cheh","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0850","doi-asserted-by":"crossref","first-page":"e68346","DOI":"10.1371\/journal.pone.0068346","article-title":"Cenderitide-eluting film for potential cardiac patch applications","volume":"8","author":"Ng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0855","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jjcc.2011.01.002","article-title":"Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides","volume":"57","author":"Nishikimi","year":"2011","journal-title":"J Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0860","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1126\/science.1079368","article-title":"Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide","volume":"299","author":"Nisoli","year":"2003","journal-title":"Sci AAAS"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0865","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(89)90714-9","article-title":"Effects of UK 69 578: a novel atriopeptidase inhibitor","volume":"334","author":"Northridge","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0870","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1373\/49.9.1560","article-title":"Stability of N-terminal pro-brain natriuretic peptide after storage frozen for one year and after multiple freeze\u2013thaw cycles","volume":"49","author":"Nowatzke","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0875","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.2337\/db12-1179","article-title":"Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humans","volume":"62","author":"Nowotny","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0880","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of nesiritide in patients with acute decompensated heart failure","volume":"365","author":"O'Connor","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0885","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.HYP.0000179575.13739.72","article-title":"N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome","volume":"46","author":"Olsen","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0890","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1463-1326.2008.00924.x","article-title":"Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction","volume":"11","author":"Oltman","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0895","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.RES.0000256354.95791.f1","article-title":"Overview of PDEs and their regulation","volume":"100","author":"Omori","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0900","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.peptides.2013.01.018","article-title":"Angiotensin III stimulates high stretch-induced ANP secretion via angiotensin type 2 receptor","volume":"42","author":"Park","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0905","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2013.10.004","article-title":"Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler","volume":"18","author":"Perry","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0910","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1055\/s-0029-1233459","article-title":"Associations between circulating N-terminal pro-Brain Natriuretic Peptide (NT-proBNP) and adiponectin concentrations depend on obesity level in female adolescents: gender dimorphic findings","volume":"41","author":"Pervanidou","year":"2009","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0915","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pharmthera.2013.06.001","article-title":"Regulation of metabolism by cGMP","volume":"140","author":"Pfeifer","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0920","doi-asserted-by":"crossref","first-page":"e1001112","DOI":"10.1371\/journal.pmed.1001112","article-title":"Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies","volume":"8","author":"Pfister","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0925","first-page":"R1457","article-title":"Renal and vascular effects of C-type and atrial natriuretic peptides in humans","volume":"273","author":"Pham","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0930","doi-asserted-by":"crossref","first-page":"E731","DOI":"10.1210\/jc.2011-2839","article-title":"Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity?","volume":"97","author":"Pivovarova","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0935","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2011.05.042","article-title":"Lipolytic effects of B-type natriuretic peptide1\u201332 in adipose tissue of heart failure patients compared with healthy controls","volume":"58","author":"Polak","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0940","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0895-7061(95)00435-1","article-title":"Relaxant effect of human brain natriuretic peptide on human artery and vein tissue","volume":"9","author":"Protter","year":"1996","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0945","doi-asserted-by":"crossref","first-page":"E857","DOI":"10.1152\/ajpendo.00459.2003","article-title":"Exercise training increases intramyocellular lipid and oxidative capacity in older adults","volume":"287","author":"Pruchnic","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0950","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1126\/science.286.5443.1368","article-title":"Activation of PPARgamma coactivator-1 through transcription factor docking","volume":"286","author":"Puigserver","year":"1999","journal-title":"Sci AAAS"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0955","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0006-291X(76)90849-4","article-title":"Mitochondrial protein alteration in active brown fat: a sodium dodecyl sulfate-polyacrylamide gel electrophoretic study","volume":"73","author":"Ricquier","year":"1976","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0960","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1016\/S0021-9258(18)32265-8","article-title":"Molecular approach to thermogenesis in brown adipose tissue. Cell-free translation of mRNA and characterization of the mitochondrial uncoupling protein","volume":"258","author":"Ricquier","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0965","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1161\/ATVBAHA.109.199893","article-title":"Reduced NO-cGMP signaling contributes to vascular inflammation and insulin resistance induced by high-fat feeding","volume":"30","author":"Rizzo","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0970","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0169-409X(02)00022-4","article-title":"Chemistry for peptide and protein PEGylation","volume":"54","author":"Roberts","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0975","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1210\/en.2010-0119","article-title":"The atrial natriuretic peptide and guanylyl cyclase-a system modulates pancreatic beta-cell function","volume":"151","author":"Ropero","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0980","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.healun.2004.07.006","article-title":"Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure","volume":"23","author":"Rothenburger","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0990","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jacc.2005.12.081","article-title":"Association of atrial natriuretic peptide and type A natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension","volume":"48","author":"Rubattu","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0985","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/HJH.0b013e32803cae3c","article-title":"Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass","volume":"25","author":"Rubattu","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb0995","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1007\/s00125-012-2724-9","article-title":"Acarbose treatment enhances mid-regional pro-atrial natriuretic peptide concentrations in non-diabetic individuals: further evidence for a common cardiometabolic pathway?","volume":"55","author":"Rudovich","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb3000","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(09)61966-8","article-title":"Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study","volume":"375","author":"Ruilope","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1005","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1172\/JCI23360","article-title":"Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide","volume":"115","author":"Sabrane","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1010","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1001\/jama.293.15.1900","article-title":"Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials","volume":"293","author":"Sackner-Bernstein","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1015","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.0000159340.93220.E4","article-title":"Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure","volume":"111","author":"Sackner-Bernstein","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1020","first-page":"1957","article-title":"Blunted vascular and renal effects of exogenous atrial natriuretic peptide in patients with Cushing's disease","volume":"86","author":"Sala","year":"2001","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1025","first-page":"33","article-title":"Factors associated with the prevalence of hypertension in the southeastern united states: insights from 69 211 Blacks and Whites in the Southern Community Cohort Study","volume":"7","author":"Sampson","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1030","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF03349021","article-title":"Expression of natriuretic peptide receptors in human adipose and other tissues","volume":"19","author":"Sarzani","year":"1996","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/sj.ijo.0803724","article-title":"Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth","volume":"32","author":"Sarzani","year":"2007","journal-title":"Int J Obes"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1050","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/00004872-199511000-00004","article-title":"Fasting inhibits natriuretic peptides clearance receptor expression in rat adipose tissue","volume":"13","author":"Sarzani","year":"1995","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb2020","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/00004872-199917090-00010","article-title":"A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives","volume":"17","author":"Sarzani","year":"1999","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/oby.2004.44","article-title":"Natriuretic peptide clearance receptor alleles and susceptibility to abdominal adiposity","volume":"12","author":"Sarzani","year":"2004","journal-title":"Obes Res"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1055","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.ahj.2005.01.051","article-title":"Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise","volume":"150","author":"Scharhag","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1060","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jacc.2006.04.073","article-title":"Norepinephrine transporter inhibition prevents tilt-induced pre-syncope","volume":"48","author":"Schroeder","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1065","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.peptides.2004.08.027","article-title":"C-type natriuretic peptide and guanylyl cyclase B receptor","volume":"26","author":"Schulz","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1070","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/0092-8674(89)90513-8","article-title":"The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family","volume":"58","author":"Schulz","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/nyas.12277","article-title":"Systemic control of brown fat thermogenesis: integration of peripheral and central signals","volume":"1302","author":"Schulz","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1080","doi-asserted-by":"crossref","first-page":"40409","DOI":"10.1074\/jbc.R110.182451","article-title":"Endogenous ligands for nuclear receptors: digging deeper","volume":"285","author":"Schupp","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1085","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1096\/fj.14.10.1345","article-title":"Natriuretic peptides: a new lipolytic pathway in human adipocytes","volume":"14","author":"Sengen\u00e8s","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1090","doi-asserted-by":"crossref","first-page":"48617","DOI":"10.1074\/jbc.M303713200","article-title":"Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes","volume":"278","author":"Sengen\u00e8s","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1095","doi-asserted-by":"crossref","first-page":"R257","DOI":"10.1152\/ajpregu.00453.2001","article-title":"Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity","volume":"283","author":"Sengen\u00e8s","year":"2002","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1100","doi-asserted-by":"crossref","first-page":"F665","DOI":"10.1152\/ajprenal.2001.281.4.F665","article-title":"Genetic disruption of atrial natriuretic peptide receptor-A alters renin and angiotensin II levels","volume":"281","author":"Shi","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1105","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2169\/internalmedicine.52.9051","article-title":"Dilated cardiomyopathy as a presenting feature of Cushing's syndrome","volume":"52","author":"Shibusawa","year":"2013","journal-title":"Intern Med"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1152\/ajplegacy.1964.206.1.143","article-title":"Thermogenesis of brown adipose tissue in cold-acclimated rats","volume":"206","author":"Smith","year":"1964","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0014-5793(88)80400-9","article-title":"Brain natriuretic factor Augmentation of cellular cyclic GMP, activation of particulate guanylate cyclase and receptor binding","volume":"232","author":"Song","year":"1988","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1120","first-page":"963","article-title":"Atrial natriuretic factor inhibits sodium transport in medullary collecting duct","volume":"250","author":"Sonnenberg","year":"1986","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1125","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.bbrc.2011.05.143","article-title":"Atrial natriuretic peptide regulates lipid mobilization and oxygen consumption in human adipocytes by activating AMPK","volume":"410","author":"Souza","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1130","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1001\/jama.1978.03290150053024","article-title":"Weight and blood pressure: findings in hypertension screening of 1 million americans","volume":"240","author":"Stamler","year":"1978","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1135","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/ijo.2010.227","article-title":"Neprilysin, obesity and the metabolic syndrome","volume":"35","author":"Standeven","year":"2011","journal-title":"Int J Obes"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/MAJ.0b013e318271c012","article-title":"Obesity, brain natriuretic peptide levels and mortality in patients hospitalized with heart failure and preserved left ventricular systolic function","volume":"345","author":"Stavrakis","year":"2013","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1145","doi-asserted-by":"crossref","first-page":"H1318","DOI":"10.1152\/ajpheart.1992.263.4.H1318","article-title":"Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma","volume":"263","author":"Stingo","year":"1992","journal-title":"Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1150","doi-asserted-by":"crossref","first-page":"15146","DOI":"10.1016\/S0021-9258(17)43785-9","article-title":"Phosphorylation of hormone-sensitive lipase by cyclic AMP-dependent protein kinase","volume":"258","author":"Stralfors","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1155","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1073\/pnas.81.11.3317","article-title":"Hormonal regulation of hormone-sensitive lipase in intact adipocytes: identification of phosphorylated sites and effects on the phosphorylation by lipolytic hormones and insulin","volume":"81","author":"Stralfors","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1160","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/332078a0","article-title":"A new natriuretic peptide in porcine brain","volume":"332","author":"Sudoh","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1165","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0006-291X(90)92401-K","article-title":"C-Type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain","volume":"168","author":"Sudoh","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1170","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1210\/endo.130.1.1309330","article-title":"Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide","volume":"130","author":"Suga","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1175","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1172\/JCI115933","article-title":"Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of \u201cvascular natriuretic peptide system\u201d","volume":"90","author":"Suga","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1180","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1507\/endocrj.K10E-067","article-title":"Association of plasma B-type natriuretic peptide levels with obesity in a general urban Japanese population: the Suita Study","volume":"57","author":"Sugisawa","year":"2010","journal-title":"Endocr J"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1185","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1253\/circj.69.283","article-title":"Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the \u2018real world\u2019 of therapy","volume":"69","author":"Suwa","year":"2005","journal-title":"Circ J"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1190","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/jcph.197","article-title":"Acute heart failure volume control multicenter randomized (AVCMA) trial: comparison of tolvaptan and carperitide","volume":"53","author":"Suzuki","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1195","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/eurjhf\/hft067","article-title":"Increased catabolic activity in adipose tissue of patients with chronic heart failure","volume":"15","author":"Szabo","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1200","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000181831","article-title":"Plasma concentration of atrial natriuretic hormone during endogenous glucocorticoid hypercorticism","volume":"34","author":"Tabarin","year":"1990","journal-title":"Horm Res"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1205","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1073\/pnas.070371497","article-title":"Cardiac fibrosis in mice lacking brain natriuretic peptide","volume":"97","author":"Tamura","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1210","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ejheart.2008.02.005","article-title":"Effect of atrial natriuretic peptide on adiponectin in patients with heart failure","volume":"10","author":"Tanaka","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1215","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/oby.2009.407","article-title":"Relationships of BMI to cardiovascular risk factors differ by ethnicity","volume":"18","author":"Taylor","year":"2010","journal-title":"Obesity"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1220","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/ejcn.2010.47","article-title":"Epigallocatechin-3-gallate and postprandial fat oxidation in overweight\/obese male volunteers: a pilot study","volume":"64","author":"Thielecke","year":"2010","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1225","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1152\/japplphysiol.00247.2012","article-title":"The kinetics of highly sensitive cardiac troponin T release after prolonged treadmill exercise in adolescent and adult athletes","volume":"113","author":"Tian","year":"2012","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1230","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2265.2011.04206.x","article-title":"Clinical relevance of cardiac structure and function abnormalities in patients with Cushing's syndrome before and after cure","volume":"76","author":"Toja","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1235","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJMe1103116","article-title":"The lost decade of nesiritide","volume":"365","author":"Topol","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1240","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1093\/eurheartj\/ehm217","article-title":"Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial","volume":"28","author":"Torp-Pedersen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1245","doi-asserted-by":"crossref","first-page":"14288","DOI":"10.1074\/jbc.C500024200","article-title":"A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn\/cn mouse","volume":"280","author":"Tsuji","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1250","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/00005344-198611000-00005","article-title":"Increase in circulating insulin induced by atrial natriuretic peptide in normal humans","volume":"8","author":"Uehlinger","year":"1986","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1255","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/01.HYP.10.3.249","article-title":"Pressure dependence of atrial natriuretic peptide during norepinephrine infusion in humans","volume":"10","author":"Uehlinger","year":"1987","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1260","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/er.2011-1052","article-title":"Cardiovascular biology of the incretin system","volume":"33","author":"Ussher","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1265","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0008-6363(99)00234-5","article-title":"Effects of brain natriuretic peptide on forearm vasculature: comparison with atrial natriuretic peptide","volume":"44","author":"van der Zander","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1270","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/jama.288.10.1252","article-title":"Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham Heart Study","volume":"288","author":"Vasan","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1275","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1280","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.2337\/db11-1466","article-title":"B-type natriuretic peptide modulates ghrelin, hunger, and satiety in healthy men","volume":"61","author":"Vila","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1285","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.cardiores.2006.08.018","article-title":"Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure","volume":"73","author":"von Haehling","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1290","doi-asserted-by":"crossref","first-page":"14332","DOI":"10.1016\/S0021-9258(17)42597-X","article-title":"Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues","volume":"259","author":"Waldman","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1305","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1056\/NEJMcibr1204796","article-title":"The natriuretic peptides and fat metabolism","volume":"367","author":"Wang","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1310","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/CIRCULATIONAHA.106.655142","article-title":"Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals","volume":"115","author":"Wang","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1315","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.0000112582.16683.EA","article-title":"Impact of obesity on plasma natriuretic peptide levels","volume":"109","author":"Wang","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1300","article-title":"Serum atrial natriuretic peptide level inversely associates with metabolic syndrome in older adults","author":"Wang","year":"2013","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1295","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1161\/01.CIR.0000062646.09566.CC","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1320","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00726-005-0289-3","article-title":"Strategies to improve plasma half life time of peptide and protein drugs","volume":"30","author":"Werle","year":"2006","journal-title":"Amino Acids"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1330","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2007.03.071","article-title":"Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction: a randomized, double-blind, placebo-controlled clinical trial","volume":"50","author":"Witteles","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1335","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.2337\/db12-0718","article-title":"Intracerebroventricular administration of C-type natriuretic peptide suppresses food intake via activation of the melanocortin system in mice","volume":"62","author":"Yamada-Goto","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1340","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1210\/jcem-67-2-348","article-title":"Plasma levels of atrial natriuretic hormone in Cushing's syndrome","volume":"67","author":"Yamaji","year":"1988","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1345","doi-asserted-by":"crossref","first-page":"8525","DOI":"10.1073\/pnas.150149097","article-title":"Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme","volume":"97","author":"Yan","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1350","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/CIRCHEARTFAILURE.108.767483","article-title":"Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial","volume":"1","author":"Yancy","year":"2008","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1355","first-page":"11695","article-title":"Natriuretic peptide regulation of endochondral ossification: evidence for possible roles of the C-type natriuretic peptide\/guanylyl cyclase-B pathway","volume":"273","author":"Yasoda","year":"1998","journal-title":"J Biochem"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1360","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/01.CIR.84.4.1581","article-title":"Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure","volume":"84","author":"Yoshimura","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1365","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1210\/en.2009-0468","article-title":"Atrial natriuretic peptide promotes pancreatic Islet \u03b2-cell growth and Akt\/Foxo1a\/Cyclin D2 signaling","volume":"150","author":"You","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1370","doi-asserted-by":"crossref","first-page":"E435","DOI":"10.1152\/ajpendo.00398.2010","article-title":"Long-term treatment with atrial natriuretic peptide inhibits ATP production and insulin secretion in rat pancreatic islets","volume":"300","author":"You","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2014.04.007_bb1375","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cmet.2011.12.018","article-title":"FAT SIGNALS \u2014 lipases and lipolysis in lipid metabolism and signaling","volume":"15","author":"Zechner","year":"2012","journal-title":"Cell Metab"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725814000953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725814000953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T11:20:38Z","timestamp":1648898438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725814000953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":279,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0163725814000953"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2014.04.007","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2014.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}